• This is a political forum that is non-biased/non-partisan and treats every person's position on topics equally. This debate forum is not aligned to any political party. In today's politics, many ideas are split between and even within all the political parties. Often we find ourselves agreeing on one platform but some topics break our mold. We are here to discuss them in a civil political debate. If this is your first visit to our political forums, be sure to check out the RULES. Registering for debate politics is necessary before posting. Register today to participate - it's free!

GOP balks at Trump's proposed drug price controls

Greenbeard

DP Veteran
Joined
Aug 10, 2013
Messages
14,756
Reaction score
13,132
Location
Cambridge, MA
Gender
Male
Political Leaning
Slightly Liberal
In the unlikely event the Trump administration sticks with the proposal it rolled out recently to set Medicare drug prices based on international prices, it's setting up a fight with the GOP and the right.

Will it stick to its guns and enrage its ideological allies by embracing price controls?

Or will it retreat from the only ideas it has come up with to try and make good on Trump's dormant campaign pledge to do something about drug prices, even as the industry thumbs its nose at his bluster ("Pfizer raises drug prices again, rebuking Trump ")?

GOP balks at Trump drug pricing plan
Republican opposition is building to a proposal from President Trump to lower drug prices in Medicare.

The rare break between Trump and Republican allies follows an aggressive step from the president in October that would tie certain Medicare drug prices to lower prices in other countries, a departure from the traditional GOP position.
But critics worry the move is essentially importing price controls from other countries, which is anathema to free-market minded Republicans, who are pushing back.

“I understand that we do want to get drug prices down but I think that any proposal that would lead to government price-fixing in that space is a pathway we don't want to follow,” Rep. Larry Bucshon (R-Ind.), the first GOP lawmaker to publicly criticize the proposal, told The Hill.

Fifty-five conservative groups and activists sent HHS a strongly worded letter last week objecting to the proposal:
The proposed payment model imports foreign price controls into the U.S. by modifying the Part B reimbursement rate so that it is calculated based off the prices set by 14 countries.

Instead of relying on government price setting, Medicare Part B is currently calculated based on market prices. The formula, which is based on the “Average Sales Price” (ASP) in the U.S. market, includes the discounts negotiated between payers, hospitals and health plans. Recently this system led to a 0.8 percent decrease in the cost of the top 50 Part B drugs.

In contrast, foreign countries frequently utilize a range of arbitrary and market distorting policies to determine the cost of medicines – by definition such approaches are price controls. There is no negotiation and foreign governments often force innovators to accept lower prices in a “take-it-or-leave it” proposition. This results in reduced or restricted access to new medicines and higher prices for those medicines that enter the market.

Conservatives have long opposed price controls because they utilize government power to forcefully lower costs in a way that distorts the economically-efficient behavior and natural incentives created by the free market.

When imposed on medicines, price controls suppress innovation and access to new medicines. This deters the development and supply of new life saving and life improving medicines to the determent of consumers, patients, and doctors.

Stephen Moore is making the same argument in the National Review: Drug-Price Controls Can Be Injurious to Your Health
But Trump should beware. No one benefits if the U.S. — even inadvertently — imports unreasonable price controls from other nations that would erase the profits from creating the drugs in the first place. Many studies have shown that when nations artificially lower prices for drugs and other American-made health innovations, the very R&D spending that leads to miracle treatments and cures falls.

This could get interesting, assuming Trump doesn't fold quickly.
 

What if...?

DP Veteran
Joined
Sep 10, 2010
Messages
30,710
Reaction score
11,674
Gender
Male
Political Leaning
Other
In the unlikely event the Trump administration sticks with the proposal it rolled out recently to set Medicare drug prices based on international prices, it's setting up a fight with the GOP and the right.

Will it stick to its guns and enrage its ideological allies by embracing price controls?

Or will it retreat from the only ideas it has come up with to try and make good on Trump's dormant campaign pledge to do something about drug prices, even as the industry thumbs its nose at his bluster ("Pfizer raises drug prices again, rebuking Trump ")?

GOP balks at Trump drug pricing plan



Fifty-five conservative groups and activists sent HHS a strongly worded letter last week objecting to the proposal:


Stephen Moore is making the same argument in the National Review: Drug-Price Controls Can Be Injurious to Your Health


This could get interesting, assuming Trump doesn't fold quickly.

So we should just be able to order cheaper drugs wherever they are available.

Corporate persons enjoy price differentials, why not natural ones?
 

Rexedgar

Yo-Semite!
Supporting Member
DP Veteran
Monthly Donator
Joined
Apr 6, 2017
Messages
37,521
Reaction score
24,005
Gender
Male
Political Leaning
Independent
Remember when Trump irked the NRA? After the White House meeting, the tone changed.........




https://usat.ly/2HX0HoZ

Big Pharma meeting in the future?
 

bearpoker

aspiring cat lady
DP Veteran
Joined
May 12, 2017
Messages
17,237
Reaction score
10,043
Location
Tennessee
Gender
Female
Political Leaning
Liberal
In the unlikely event the Trump administration sticks with the proposal it rolled out recently to set Medicare drug prices based on international prices, it's setting up a fight with the GOP and the right.

Will it stick to its guns and enrage its ideological allies by embracing price controls?

Or will it retreat from the only ideas it has come up with to try and make good on Trump's dormant campaign pledge to do something about drug prices, even as the industry thumbs its nose at his bluster ("Pfizer raises drug prices again, rebuking Trump ")?

GOP balks at Trump drug pricing plan



Fifty-five conservative groups and activists sent HHS a strongly worded letter last week objecting to the proposal:


Stephen Moore is making the same argument in the National Review: Drug-Price Controls Can Be Injurious to Your Health


This could get interesting, assuming Trump doesn't fold quickly.

It's not really price controls. The customer is offering to buy at a price. The seller is free to reject the offer and sell to someone else.
 

Greenbeard

DP Veteran
Joined
Aug 10, 2013
Messages
14,756
Reaction score
13,132
Location
Cambridge, MA
Gender
Male
Political Leaning
Slightly Liberal
Remember when Trump irked the NRA? After the White House meeting, the tone changed.........




https://usat.ly/2HX0HoZ

Big Pharma meeting in the future?


The proposal in the OP is about Medicare Part B but what you're describing already happened for Medicare Part D. Way back in Trump's first few days in office.

After meeting with pharma lobbyists, Trump drops promise to negotiate drug prices
A lot happened in the 2016 campaign, but one of the things Donald Trump did to win the election was shift to the left on a number of key issues — promising to avoid cuts in Social Security and Medicare benefits and adopting a longstanding Democratic pledge to let Medicare negotiate bulk discounts in the price it pays for prescription drugs.

Today, after a meeting with pharmaceutical industry lobbyists and executives, he abandoned that pledge, referring to an idea he supported as recently as three weeks ago as a form of “price fixing” that would hurt “smaller, younger companies.” Instead of getting tough, Trump’s new plan is that he’s “going to be lowering taxes” and “getting rid of regulations.”

Hence my skepticism that when the going gets tough the current proposal will survive. He's starting to bleed ideological allies.
 

Captain America

Jedi Master
Supporting Member
DP Veteran
Joined
Feb 12, 2006
Messages
22,906
Reaction score
13,207
Location
Wisconsin
Gender
Male
Political Leaning
Centrist
It costs so much money to get a drug to market.

R&D. Regulations. FDA, etc.

Plus, in the few years they have to recoup all that expense, they also have to recoup the expense they wasted on the drugs that DIDN'T make it to market.

Foreign governments tend to heavy-hand big pharma telling them what they can and cannot charge.

Meanwhile, American's foot the expense for the R&D, regs, FDA, etc.... And people half way across reap the benefit of getting the drugs cheaper than we can.

Just my opinion. Not an expert on the subject by any means.
 
Top Bottom